These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6672998

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E.
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic lowering of fibrinogen levels].
    Ernst E.
    MMW Munch Med Wochenschr; 1983 May 27; 125(21):83-4. PubMed ID: 6410202
    [No Abstract] [Full Text] [Related]

  • 5. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC.
    Thromb Diath Haemorrh Suppl; 1973 May 27; 56():239-51. PubMed ID: 4617331
    [No Abstract] [Full Text] [Related]

  • 6. [Hemodilution, defibrinogenation and plasmapheresis in hemorheology].
    Bartolo M.
    Ric Clin Lab; 1985 May 27; 15 Suppl 1():439-54. PubMed ID: 4035226
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E.
    MMW Munch Med Wochenschr; 1983 Sep 16; 125(37):796-8. PubMed ID: 6415441
    [No Abstract] [Full Text] [Related]

  • 8. Blood viscosity and thrombosis: clinical considerations.
    Smith BD, La Celle PL.
    Prog Hemost Thromb; 1982 Sep 16; 6():179-201. PubMed ID: 6762612
    [Abstract] [Full Text] [Related]

  • 9. Subcutaneous ancrod after operation for fractured hip--a dose-ranging and feasibility study.
    Lowe GD, Morrice JJ, Fulton A, Forbes CD, Prentice CR, Barbenel JC.
    Thromb Haemost; 1978 Aug 31; 40(1):134-43. PubMed ID: 725844
    [Abstract] [Full Text] [Related]

  • 10. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
    Urano T, Ihara H, Takada Y, Fujie M, Takada A.
    Blood Coagul Fibrinolysis; 2000 Mar 31; 11(2):145-53. PubMed ID: 10759007
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA, Goyle KB.
    Br J Surg; 1976 Aug 30; 63(8):661-2. PubMed ID: 953495
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, Huang XX, Zhai ZG.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 20; 87(43):3074-8. PubMed ID: 18261355
    [Abstract] [Full Text] [Related]

  • 18. Blood and plasma viscosity in experimentally induced hyper- and hypo-fibrinogenaemia.
    Pola P, Flore R, Tondi P.
    Int J Tissue React; 1986 Nov 20; 8(4):333-6. PubMed ID: 2943690
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes--a multicentre trial.
    Latallo ZS.
    Thromb Haemost; 1983 Aug 30; 50(2):604-9. PubMed ID: 6227104
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.